Sunshine Biopharma (SBFM.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Dec12

Sunlight Biopharmaceutical's Annual Shareholders' Meeting Approves Revision of Stock Incentive Plan

21:06

Nov14

Sunshine Biopharma released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 9.417 M (forecast USD 11.1 M), actual EPS USD -0.1939 (forecast USD -0.13)

04:00

Sunshine Biopharma released FY2025 9 Months Earnings on November 13, 2025 (EST), with actual revenue of USD 27.73 M and EPS of USD -1.0202

04:00

Oct28

Sunora Pharma Subsidiary Nora Pharma Receives Approval for Domperidone in Canada

11:46

Oct16

Sunshine Biopharma's Subsidiary Nora Pharma Launches Pravastatin in Canada

11:45

Oct14

Sunshine Biopharma Purchases $5 Million Worth of Bitcoin

12:30

Schedules & Filings

Schedules

Filings

Nov13

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 9.417 M, Net Income -883.82 K, EPS -0.1939

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 9.41 M, Net Income -1.771 M, EPS -0.3938

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 8.901 M, Net Income -1.18 M, EPS -0.4364

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change